Načítá se...
Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
Immune checkpoint inhibitors have quickly become a critical component to the management of advanced renal cell carcinoma. These therapies have been approved for patients who are treatment-naïve and who have progressed on anti-angiogenesis agents. Combinations of immune checkpoint inhibitors with ant...
Uloženo v:
| Vydáno v: | Semin Nephrol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7164329/ https://ncbi.nlm.nih.gov/pubmed/32130969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semnephrol.2019.12.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|